Cl Transport in Complemented CF Bronchial Epithelial Cells Correlates with CFTR mRNA Expression LevelsIllek B.2 · Maurisse R.1 · Wahler L.2 · Kunzelmann K.3 · Fischer H.2 · Gruenert D.C.1,4
1California Pacific Medical Center Research Institute, San Francisco,2Children’s Hospital Oakland Research Institute, Oakland,3University of Regensburg, Regensburg,4Department of Laboratory Medicine, University of California, San Francisco and Department of Medicine, University of Vermont, Burlington,*These authors contributed equally to this manuscript
Dieter C Gruenert, PhD,
California Pacific Medical Center Research Institute,
475 Brannan, Suite 220, San Francisco, CA 94107 (USA)
Tel. +1 415-600-1362, Fax: +1 415-600-1725
Do you have an account?
Little is known about the relationship between CF transmembrane conductance regulator (CFTR) gene expression and the corresponding transport of Cl. The phenotypic characteristics of polarized ΔF508 homozygote CF bronchial epithelial (CFBE41o-) cells were evaluated following transfection with episomal expression vector containing either full-length (6.2kb) wild type (wt) and (4.7kb) ΔF508CFTR cDNA. Forskolin-stimulated Cl secretion in two clones expressing the full-length wild type CFTR was assessed; clone c7-6.2wt gave 13.4±2.5 µA/cm2 and clone c10-6.2wt showed 41.3±25.3 µA/cm2. Another clone (c4-4.7ΔF) complemented with the ΔF508 CFTR cDNA showed high and stable expression of vector-derived ΔF508 CFTR mRNA and a small cAMP-stimulated Cl current (4.7±0.7 µA/cm2) indicating ΔF508CFTR trafficking to the plasma membrane at physiological temperatures. Vector-driven CFTR mRNA levels were 5-fold (c7-6.2wt), 14-fold (c10-6.2wt), and 27-fold (c7-4.7ΔF) higher than observed in normal bronchial epithelial cells (16HBE14o-) endogenously expressing wtCFTR. Assessment of CFTR mRNA levels and CFTR function showed that cAMP-stimulated CFTR Cl currents were 33%, 167% and 24%, respectively, of those in 16HBE14o- cells. The data suggest that transgene expression needs to be significantly higher than endogenously expressed CFTR to restore functional wtCFTR Cl transport to levels sufficient to reverse CF pathology.
© 2008 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.